Pseudomonas Stutzeri InfectionsSymptoms, Doctors, Treatments, Advances & More
Learn About Pseudomonas Stutzeri Infections
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Felix Ratjen practices practicing medicine in Toronto, Canada. Mr. Ratjen is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Pseudomonas Stutzeri Infections, Hereditary Hemorrhagic Telangiectasia, Lung Transplant, and Liver Embolization.
Susanne Haussler practices practicing medicine in Hannover, Germany. Ms. Haussler is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Pseudomonas Stutzeri Infections, Cystic Fibrosis, Salmonella Enterocolitis, and Hospital-Acquired Pneumonia.
Michael Parkins practices practicing medicine in Calgary, Canada. Mr. Parkins is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Pseudomonas Stutzeri Infections, Pulmonary Aspergilloma, Vulvectomy, and Lung Transplant.
Summary: Background Mechanical ventilation is an essential medical intervention in the context of critical illness. However, the intervention is associated with a risk of significant, potentially preventable complications. Among these are ventilator-associated pneumonia, sepsis, acute respiratory distress syndrome, atelectasis, and pulmonary edema. Ventilator-associated complications commonly increase morb...
Summary: A double-blind, active-controlled, multiple-ascending dose, safety study of aerosolized RSP-1502 in subjects with cystic fibrosis Pseudomonas aeruginosa lung infection.